Save your place

Sign in to WhoBought

Please try again later.

Design Therapeutics, Inc. (DSGN) institutional ownership

Latest close $11.78 Jul 22, 2026
Market cap$217M 52-week range SectorHealthcare
Funds holding · Q1 2026
114
reported DSGN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
73 buyers · 41 sellers

Design Therapeutics, Inc. (DSGN) price and institutional activity

Dates

Q1 2026

$0 bought by 73 investors
Ra Capital Management, L.P.Trails Edge Capital Partners, LP +71 more
$0 sold by 41 investors
Point72 Asset Management, L.P.Logos Global Management LP +39 more
Bought Sold Totals per quarter; hover a bar for the names.

Design Therapeutics, Inc. (DSGN) institutional activity · 114

Investor Type Est. change Change Δ Own Date
Point72 Asset Management, L.P. · Reduced
Change −2.6M Δ Own −49.3% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −2.6M −49.3% Q1 2026
Ra Capital Management, L.P. · Added
Change +1.5M Date Q1 2026
Ra Capital Management, L.P. Added· Q1 2026 +1.5M Q1 2026
Trails Edge Capital Partners, LP · New
Change +852K Date Q1 2026
Trails Edge Capital Partners, LP New· Q1 2026 +852K Q1 2026
Driehaus Capital Management LLC · Added
Change +565K Date Q1 2026
Driehaus Capital Management LLC Added· Q1 2026 +565K Q1 2026
Logos Global Management LP · Reduced
Change −550K Date Q1 2026
Logos Global Management LP Reduced· Q1 2026 −550K Q1 2026
Frazier Life Sciences Management, L.P. · Exited
Change −521K Δ Own −100.0% Date Q1 2026
Frazier Life Sciences Management, L.P. Exited· Q1 2026 −521K −100.0% Q1 2026
Baker Bros. Advisors LP · Added
Change +353K Date Q1 2026
Baker Bros. Advisors LP Added· Q1 2026 +353K Q1 2026
Goldman Sachs Group Inc · Added
Change +234K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +234K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −228K −49.7% Q1 2026
Kennedy Capital Management LLC · Added
Change +222K Date Q1 2026
Kennedy Capital Management LLC Added· Q1 2026 +222K Q1 2026
Invesco Ltd. · Reduced
Change −164K Δ Own −53.6% Date Q1 2026
Invesco Ltd. Reduced· Q1 2026 −164K −53.6% Q1 2026
Dimensional · Added
Change +134K Date Q1 2026
Dimensional Added· Q1 2026 +134K Q1 2026
Ameriprise Financial Inc · Reduced
Change −123K Date Q1 2026
Ameriprise Financial Inc Reduced· Q1 2026 −123K Q1 2026
Jane Street Group, LLC · Reduced
Change −123K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −123K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +121K +42.2% Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 114

Famous investor activity in Design Therapeutics, Inc. (DSGN)

Design Therapeutics, Inc. (DSGN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
George Simeon · Director Grant (A) 30K
Owned 30K Trade date Jun 9, 2026 Filed date Jun 11, 2026
George Simeon Director Grant (A) 30K 30K Jun 9, 2026 Jun 11, 2026
Schmid John P. · Director Grant (A) 30K
Owned 30K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Schmid John P. Director Grant (A) 30K 30K Jun 9, 2026 Jun 11, 2026
Lappe Rodney W. · Director Grant (A) 30K
Owned 30K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Lappe Rodney W. Director Grant (A) 30K 30K Jun 9, 2026 Jun 11, 2026
Gover Justin D. · Director Grant (A) 30K
Owned 30K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Gover Justin D. Director Grant (A) 30K 30K Jun 9, 2026 Jun 11, 2026
Shapiro David · Director Grant (A) 30K
Owned 30K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Shapiro David Director Grant (A) 30K 30K Jun 9, 2026 Jun 11, 2026
Berger Heather A. · Director Grant (A) 30K
Owned 30K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Berger Heather A. Director Grant (A) 30K 30K Jun 9, 2026 Jun 11, 2026
Shapiro David · Director 2 operations 68K
Owned 8K Trade date Mar 31, 2026 Filed date Apr 1, 2026
Shapiro David Director 2 operations 68K 8K Mar 31, 2026 Apr 1, 2026
Storgard Chris · Officer Grant (A) 250K
Owned 250K Trade date Jan 2, 2026 Filed date Jan 5, 2026
Storgard Chris Officer Grant (A) 250K 250K Jan 2, 2026 Jan 5, 2026
Jeffries Sean · Officer Grant (A) 375K
Owned 375K Trade date Jan 2, 2026 Filed date Jan 5, 2026
Jeffries Sean Officer Grant (A) 375K 375K Jan 2, 2026 Jan 5, 2026
Burgess Julie · Officer Grant (A) 150K
Owned 150K Trade date Jan 2, 2026 Filed date Jan 5, 2026
Burgess Julie Officer Grant (A) 150K 150K Jan 2, 2026 Jan 5, 2026
Gover Justin D. · Director Grant (A) 45K
Owned 45K Trade date Jan 2, 2026 Filed date Jan 5, 2026
Gover Justin D. Director Grant (A) 45K 45K Jan 2, 2026 Jan 5, 2026
Shah Pratik · Director, Officer Grant (A) 750K
Owned 750K Trade date Jan 2, 2026 Filed date Jan 5, 2026
Shah Pratik Director, Officer Grant (A) 750K 750K Jan 2, 2026 Jan 5, 2026
Shah Pratik · Director, Officer 2 operations 1.1M
Owned 525K Trade date Dec 9, 2025 Filed date Dec 11, 2025
Shah Pratik Director, Officer 2 operations 1.1M 525K Dec 9, 2025 Dec 11, 2025
Gover Justin D. · Director 2 operations 46K
Owned 30K Trade date Sep 9, 2025 Filed date Sep 10, 2025
Gover Justin D. Director 2 operations 46K 30K Sep 9, 2025 Sep 10, 2025
William Arsani · Director 2 operations −$3.0M
Price $5.25 Qty −563K Owned 2.7M Trade date Aug 13, 2025 Filed date Aug 14, 2025
William Arsani Director 2 operations $5.25 −563K −$3.0M 2.7M Aug 13, 2025 Aug 14, 2025
15 of 46
15 of 46 Sign in to continue to older insider transactions.

Design Therapeutics, Inc. (DSGN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ansari Aseem Z. 7.7M
% of shares outstanding 13.8% Filing date Feb 9, 2022
Ansari Aseem Z. 7.7M 13.8% Feb 9, 2022
Sr One Capital Fund I Aggregator LP 6.5M
% of shares outstanding 11.7% Filing date Dec 22, 2022
Sr One Capital Fund I Aggregator LP 6.5M 11.7% Dec 22, 2022
Logos Global Management LP 4.2M
% of shares outstanding 7.4% Filing date Aug 13, 2024
Logos Global Management LP 4.2M 7.4% Aug 13, 2024
Star Irrevocable Trust #1 Dated April 22, 2019 3.8M
% of shares outstanding 6.9% Filing date Feb 7, 2025
Star Irrevocable Trust #1 Dated April 22, 2019 3.8M 6.9% Feb 7, 2025
Light Irrevocable Trust #1 Dated April 22, 2019 3.8M
% of shares outstanding 6.9% Filing date Feb 7, 2025
Light Irrevocable Trust #1 Dated April 22, 2019 3.8M 6.9% Feb 7, 2025
Light Irrevocable Trust #1 Dated April 22, 2019 3.8M
% of shares outstanding 6.9% Filing date Feb 9, 2022
Light Irrevocable Trust #1 Dated April 22, 2019 3.8M 6.9% Feb 9, 2022
Star Irrevocable Trust #1 Dated April 22, 2019 3.8M
% of shares outstanding 6.9% Filing date Feb 9, 2022
Star Irrevocable Trust #1 Dated April 22, 2019 3.8M 6.9% Feb 9, 2022
Ra Capital Management, L.P. 3.0M
% of shares outstanding 5.3% Filing date Oct 13, 2022
Ra Capital Management, L.P. 3.0M 5.3% Oct 13, 2022
8 of 17

Design Therapeutics, Inc. (DSGN) ownership FAQ

Who owns DSGN?

114 reporting institutions disclosed DSGN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.